Skip to main content
. 2022 Aug 5;23(15):8716. doi: 10.3390/ijms23158716

Figure 3.

Figure 3

Distribution of Prosigna® risk groups across local surrogate (A) IHC subtypes and (B) IHC+G subtypes. IHC = immunohistochemistry; IHC+G = immunohistochemistry + tumor grade; LumA = Luminal A; LumB = Luminal B.